HIV/AIDS Treatment News: July 2010

See also: All Articles for July 2010

ACRIA Trials in Progress (Summer 2010)
To read PDF, click here.
In Achieve, from ACRIA and GMHC
TMC278 (Rilpivirine) Stands Up to Efavirenz in Battle of First-Line NNRTIs; FDA Approval May Be Drawing Near: A Blog Entry by Myles Helfand (July 28, 2010)
In The XVIII International AIDS Conference, from TheBodyPRO.com
Main Outcomes From World AIDS Forum (July 27, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Antiretroviral Treatment of Adult HIV Infection: 2010 Recommendations of the International AIDS Society-USA Panel (July 27, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV Can Be Deadly Even Before CD4 Counts Fall, Researchers Say (July 27, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
The Alphabet Soup of Immune Control: ADCC Antibodies, (Memory) B-Cells, Elite Controllers and Exposed Sero-Negatives -- Will They Amount to Z? A Blog Entry by Loreen Willenberg (July 23, 2010)
Profound discoveries from around the world on HIV controllers/long-term nonprogressors, part four.
In The XVIII International AIDS Conference, from TheBody.com
On TheBodyPRO.com
International AIDS Conference Day 5: Updates From Vienna With Carl Dieffenbach -- A Blog Entry From Positive Policy (July 22, 2010)
In The XVIII International AIDS Conference, from TheBody.com
On TheBodyPRO.com
CDC Study Finds Immune System Benefits of Pre-Exposure Prophylaxis for Animals Infected With the Monkey Form of HIV While Taking These Drugs (July 22, 2010)
From U.S. Centers for Disease Control and Prevention
Natural Killer Cells Are Prominent Factors in Control of HIV: A Blog Entry by Loreen Willenberg (July 22, 2010)
Profound discoveries from around the world on HIV controllers/long-term nonprogressors, part three.
In The XVIII International AIDS Conference, from TheBody.com
On TheBodyPRO.com
Is Participating in Vaccine Clinical Trials Worth the Risk? (July 21, 2010)
From Black AIDS Institute
On TheBodyPRO.com

VIEW ALL ARTICLES

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

TheBody.com's New! TheBody.com App
TheBody.com's Medication and Health Reminders
TheBody.com's Facebook, Widgets, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. ASO Finder U.S. ASO Listings
International ASOs

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.